Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT02878434 Recruiting - Cancer Clinical Trials

Fertility Preservation in Young Women With Cancer

Start date: May 23, 2017
Phase:
Study type: Observational [Patient Registry]

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded. Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.

NCT ID: NCT02876731 Completed - Cancer Clinical Trials

Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)

IMMETAOS
Start date: July 2013
Phase: N/A
Study type: Interventional

Prospective, monocentric, comparative, non randomised Primary objective : - to compare the diagnostic accuracy of sodium fluoride PET-CT and MRI using the conventional block and diffusion sequence in the search for bone metastases Secondary objectives : - compare accuracy of MRI diffusion and conventional MRI - explore the evolution of the results of the different types of imaging over time or under treatment for patients with repeated examinations at 6 months

NCT ID: NCT02876627 Completed - Cancer Clinical Trials

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

Start date: February 2015
Phase: Phase 1
Study type: Interventional

Introduction: The purpose of this study was to determine the effect of twelve weeks of aerobic exercise program on erythrocyte levels in women with breast cancer after chemotherapy. Methods: Thirty women with breast cancer after chemotherapy of Sydalshhda hospital (aged between 47-65 years) volunteered for this study, and then randomly selected an exercise (n = 15) and control (n = 15) groups. Exercise group completed a twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve, while the control group were followed. Blood samples including red blood cell counts (RBC), hematocrit (HCT), hemoglobin (HB), peak oxygen consumption before and after 12 weeks of aerobic exercise were measured. For analysis of data, repeated-measures analysis of variance (ANOVA) was used.

NCT ID: NCT02876510 Completed - Cancer Clinical Trials

ACTolog in Patients With Solid Cancers

ACTolog
Start date: June 30, 2017
Phase: Phase 1
Study type: Interventional

The study purpose is to learn about the safety and tolerability of IMA101 alone (Cohort 1) or in combination with atezolizumab (Cohort 2) in patients with advanced solid cancers that express pre-defined Immatics tumor targets.

NCT ID: NCT02874053 Withdrawn - Cancer Clinical Trials

The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs

Start date: June 5, 2019
Phase:
Study type: Observational

Background: People with cancer often have to make complex decisions about their treatment. For some of these decisions, they have to weigh the benefits of a treatment against its side effects. They may have to think about its potential to increase the risk of another disease. One example is hormone replacement therapy. That reduces a woman s risk of getting colorectal cancer, but it raises her risk of getting breast cancer. Researchers want to learn more about how people make tradeoff decisions like these. Objective: To learn about how people respond to information about hypothetical health and medical treatment options. Eligibility: Adults ages 18 70. Design: Participants will have one 30-minute visit. Participants will complete a series of short questionnaires. These will be about their beliefs and values. Some may be about cancer and heart disease risk. Participants ages 18 to 29 will answer questions about sexual health. Participants will write a paragraph or two about a room in their house or about a life event. Participants will read a series of stories. These will describe different hypothetical health treatments. The stories describe a pill that lowers the risk of one health condition, but raises the risk for another. After each story, participants will note how willing they are to take the pill. Participants will answer questions about the information that they got. They will also answer questions about their health, beliefs, and opinions. Participants will do 2 attention tasks computer.

NCT ID: NCT02874001 Completed - Cancer Clinical Trials

French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic Documentation

PO-BADO
Start date: July 2015
Phase: N/A
Study type: Observational

Validation of the PO-BADO in its short and long versions that need a standardized validation process with the inclusion of 450 Patients

NCT ID: NCT02873923 Completed - Cancer Clinical Trials

Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysis

DATECAN-2
Start date: October 2012
Phase:
Study type: Observational

The DATECAN-2 project aims at assessing the surrogate properties for OS of several time-to-event endpoints through meta-analyses of completed and published randomized controlled trials. Two main cancer localization are concerned: breast cancer and soft-tissue sarcomas. The impact of survival endpoints' definitions on the trials' results and conclusions will also be evaluated.

NCT ID: NCT02873533 Completed - Cancer Clinical Trials

Modification of the Quality of Life Based on Objective Geriatric Tests

MEGERIA
Start date: March 2013
Phase: N/A
Study type: Interventional

The analysis of this study will achieve an improvement in the management of patients over 70 years with adaptation of chemotherapy regimens after analysis of the subject and its psychosocial environment. The analysis of socio-economic impacts will implement actions to optimize the care of the elderly while emphasizing the value of management / cost of care.

NCT ID: NCT02872532 Recruiting - Cancer Clinical Trials

Testicular Tissue Cryopreservation in Children

Start date: August 16, 2016
Phase: N/A
Study type: Interventional

This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility threatening medical diagnoses or facing surgery, chemotherapy or radiation therapy that may cause loss of reproductive potential.

NCT ID: NCT02869802 Recruiting - Cancer Clinical Trials

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

PanGen
Start date: October 6, 2016
Phase:
Study type: Observational

Researchers are looking for better ways of understanding and treating pancreatic cancer. The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cells) and the genes within the tumour. These characteristics may be useful in choosing treatments for patients in the future. Changes (mutations) in genes have been shown to be an important characteristic in cancers. Looking at differences in genes in patients with advanced pancreatic ductal adenocarcinomas and comparing this information with response to their initial chemotherapy treatment may help to learn which treatments may be better for certain patients after initial treatment.